TrialsgrambetaRCTs are beautiful

UKPDS 33

1998

UK Prospective Diabetes Study 33

In 3,867 patients with newly diagnosed type 2 diabetes, intensive glucose control with sulfonylurea or insulin reduced microvascular endpoints compared with conventional diet-based therapy.

Result

Primary endpoint: Combined diabetes-related endpoints

HbA1c 7.0 % vs 7.9 %. Microvascular endpoints −25 % (p=0.01); macrovascular endpoints not significantly reduced.

Original publication
Subtopic
Intensive glycaemic control
Design
RCT, median 10 yr follow-up
Relevance
Practice-defining: a trial the field needs to know.
Source
UKPDS Group. Lancet. 1998;352(9131):837-853.doi 10.1016/S0140-6736(98)07019-6

Discussion & critique

Established the strategy of early glucose-lowering and the HbA1c target. The legacy effect was confirmed in the 10-year follow-up (UKPDS 80).